Exposure-Related Pulmonary Fibrosis Webinar

ICS Webinar on Occupational ILD and Drug Induced ILD - The Best Approach!Подробнее

ICS Webinar on Idiopathic Pulmonary Fibrosis The Best Approach!Подробнее

Webinar: Understanding Pulmonary Arterial Hypertension (PAH), with Dr. Roham Zamanian (2022)Подробнее

Treatments for Pulmonary FibrosisПодробнее

Integrating the Envisia Genomic Classifier to Improve ILD Diagnostic & Prognostic ConfidenceПодробнее

What Is Pulmonary Hypertension Associated with Interstitial Lung Disease | Industry Hosted WebinarПодробнее

An Introduction to Hypersensitivity Pneumonitis webinarПодробнее

Hypersensitivity Pneumonitis ICS WebinarПодробнее

Progressive Pulmonary Fibrosis: What Patients Need to Know webinarПодробнее

What is Pulmonary Fibrosis? An OverviewПодробнее

Treatment Options for Pulmonary Fibrosis WebinarПодробнее

Free Respiratory Update Webinar for GP Trainees - 14th April 2020Подробнее

Webinar: Lung DiseaseПодробнее

Symptom Management for Pulmonary FibrosisПодробнее

New Drug Approvals for Use in Scleroderma Interstitial Lung DiseaseПодробнее

Interstitial Lung Disease Webinar- 2020 Treatments, type of diseases, diagnosis, & approachesПодробнее

IOSH Webinars - Asbestos exposure, the impacts of systematic failureПодробнее

Pneumoconiosis: Pulmonary Fibrosis Caused by Occupational ExposuresПодробнее

Webinar On Interstitial Lung Diseases.Подробнее

AdAlta (ASX: 1AD) AD-214 strategy webinar : 19 July 2021Подробнее